Use of decision aids to support informed choices about screening
- 26 August 2004
- Vol. 329 (7464) , 507-510
- https://doi.org/10.1136/bmj.329.7464.507
Abstract
Introduction Patients should be able to participate in health decisions, if they so choose. Decision aids have been developed to help patients make informed decisions about treatment and have been found to improve knowledge, reduce indecision, and improve agreement between values and choice.1 However, in screening, where informed choice is not common practice,2 decision aids are controversial and their effect is currently unknown.3 4 Nevertheless, the complexities of decisions about screening mean that decision aids could be of immense value. In this paper we highlight eight issues that are critically important for the development and use of high quality decision aids about screening. Some of these issues arise because of fundamental differences between screening and treatment interventions; other issues flow from widespread uncritical support for screening, as illustrated by the storm over PSA (prostate specific antigen) screening for prostate cancer.5 6Keywords
This publication has 25 references indexed in Scilit:
- Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort studyBMJ, 2004
- Enthusiasm for Cancer Screening in the United StatesJAMA, 2004
- Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths preventedBMJ, 2003
- Decision aids for people facing health treatment or screening decisionsPublished by Wiley ,2003
- Women's understanding of abnormal cervical smear test results: a qualitative interview studyBMJ, 1997
- Informed choice for users of health services: views on ultrasonography leaflets of women in early pregnancy, midwives, and ultrasonographersBMJ, 1996
- Advances in Diagnostic Imaging and Overestimations of Disease Prevalence and the Benefits of TherapyNew England Journal of Medicine, 1993
- Labelling of hypertensives: A review of the dataJournal of Clinical Epidemiology, 1990
- Cholesterol screening programmes: how much potential benefit?BMJ, 1989
- Labeling of participants in high blood pressure screening programs. Implications for blood cholesterol screenings.1988